Especially, molecules based on the averaged/D2R model, which could exhibit an effect on all the studied targets—MAO-B, SERT, D2R, and 5-HT1AR—easing parkinsonism and depressive symptoms alike. The gene discussed is DRD2; the disease is Parkinson disease.